TECX — Tectonic Therapeutic Share News
0.000.00%
Last trade - 00:00- $412.30m
- $185.41m
Brief: Avrobio Says Received Non-Compliance Notice From Nasdaq
Brief: Avrobio To Present New Preclinical Data On Vector Safety At ESGCT Annual Congress
U.S. STOCKS ON THE MOVE-Ford, Pagaya Technologies, Nike
U.S. STOCKS ON THE MOVE-Peloton, Pagaya Technologies, AVROBIO, Ford
AVROBIO gains on 'rare pediatric disease' tag for experimental gene therapy
Brief: AVROBIO Receives Rare Pediatric Disease Designation From U.S. FDA For First Gene Therapy In Development For Cystinosis
U.S. STOCKS ON THE MOVE-Nucor, Larimar Therapeutics, gold miners
U.S. STOCKS ON THE MOVE-Johnson & Johnson, Altimmune, Twilio
U.S. STOCKS ON THE MOVE-Crypto stocks, AVROBIO, Scisparc
AVROBIO jumps on UK regulatory nod for gene therapy pediatric trial
Avrobio Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Avrobio Reports Second Quarter 2022 Financial Results
Brief: K2 Principal Fund LP Reports 5.12% Passive Stake In Avrobio Inc As Of July 28
U.S. STOCKS ON THE MOVE-JPMorgan Chase, semi equipment makers, asset managers
U.S. STOCKS ON THE MOVE-Apollo Endosurgery Inc, Twitter Inc, Domino's Pizza Inc
Avrobio jumps on 'orphan drug' tag for gene therapy
Brief: Avrobio Announces Preclinical Gene Therapy Data For Pompe Disease At ASGCT Annual Meeting
U.S. STOCKS ON THE MOVE-Block Inc, Markel Corp, AVROBIO Inc
AVROBIO up on early data from genetic disorder therapy trial